Prenatal exome sequencing analysis in fetuses with central nervous system anomalies
Ultrasound in Obstetrics & Gynecology · 2023-11 · 62 (5) · 721-726
DOI: 10.1002/uog.26254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ultrasound in Obstetrics & Gynecology, 2023-11. Verfasst von Y Zhi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Prenatal Diagnosis Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. Hauptthemen laut MEDLINE: Nervous System Malformations, Central Nervous System Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Henan Province Key R&D and Promotion Projects.
Abstract (Originalsprache)
Objective
To evaluate the utility of prenatal exome sequencing (pES) in fetuses with central nervous system (CNS) abnormalities.
Methods
This was a retrospective cohort study of fetuses identified to have CNS abnormality on prenatal ultrasound and/or magnetic resonance imaging. All fetuses were first analyzed by chromosomal microarray analysis (CMA). Fetuses with a confirmed aneuploidy or causal pathogenic copy‐number variant (CNV) on CMA did not undergo pES analysis and were excluded, while those with a negative CMA result were offered pES testing.
Results
Of the 167 pregnancies included in the study, 42 (25.1%) were identified to have a pathogenic or likely pathogenic (P/LP) variant. The diagnostic rate was significantly higher in fetuses with a non‐isolated CNS abnormality than in those with a single CNS abnormality (35.7% (20/56) vs 14.5% (8/55); P = 0.010). Moreover, when a fetus had three or more CNS abnormalities, the positive diagnostic rate increased to 42.9%. A total of 25/42 (59.5%) cases had de ‐ novo mutations, while, in the remaining cases, mutations were inherited and carried a significant risk of recurrence. Families whose fetus carried a P/LP mutation were more likely to choose advanced pregnancy termination than those with a variant of uncertain significance, secondary/incidental finding or negative pES result (83.3% (25/30) vs 41.3% (38/92); P < 0.001). Conclusion pES improved the identification of genetic disorders in fetuses with CNS anomalies without a chromosomal abnormality or CNV identified on CMA, regardless of the number of CNS anomalies and presence of extracranial abnormality. We also demonstrated that pES findings can significantly impact parental decision‐making. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Prenatal Diagnosis Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
- Scientific Research Office, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
- Clinical Laboratory, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
ORCID-Profile: Y Zhi
Förderung
- Henan Province Key R&D and Promotion Projects
Zitieren
APA
Zhi, Y., Liu, L., Wang, H., Chen, X., Lv, Y., Cui, X., Chang, H., Wang, Y., & Cui, S. (2023). Prenatal exome sequencing analysis in fetuses with central nervous system anomalies. Ultrasound in Obstetrics & Gynecology, 62(5), 721-726. https://doi.org/10.1002/uog.26254
Vancouver
Zhi Y, Liu L, Wang H, Chen X, Lv Y, Cui X, et al. Prenatal exome sequencing analysis in fetuses with central nervous system anomalies. Ultrasound in Obstetrics & Gynecology. 2023;62(5):721-726. doi:10.1002/uog.26254
BibTeX
@article{Zhi2023,
author = {Zhi, Y and Liu, L and Wang, H and Chen, X and Lv, Y and Cui, X and Chang, H and Wang, Y and Cui, S},
title = {Prenatal exome sequencing analysis in fetuses with central nervous system anomalies},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2023},
volume = {62},
number = {5},
pages = {721--726},
doi = {10.1002/uog.26254}
}
EUVIMED